company background image
2372 logo

I'rom Group TSE:2372 Stock Report

Last Price

JP¥2.78k

Market Cap

JP¥33.7b

7D

7.6%

1Y

41.0%

Updated

22 Dec, 2024

Data

Company Financials

I'rom Group Co., Ltd.

TSE:2372 Stock Report

Market Cap: JP¥33.7b

2372 Stock Overview

Engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. More details

2372 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health2/6
Dividends0/6

Risk Analysis

Interest payments are not well covered by earnings

Large one-off items impacting financial results

Profit margins (1.4%) are lower than last year (9.5%)


My Notes

Capture your thoughts, links and company narrative

I'rom Group Co., Ltd. Competitors

EUCALIA

TSE:286A

JP¥29.5b

Solasto

TSE:6197

JP¥42.4b

France Bed HoldingsLtd

TSE:7840

JP¥44.2b

CUC

TSE:9158

JP¥46.6b

Price History & Performance

Summary of share price highs, lows and changes for I'rom Group
Historical stock prices
Current Share PriceJP¥2,783.00
52 Week HighJP¥2,790.00
52 Week LowJP¥1,750.00
Beta0.38
1 Month Change7.12%
3 Month Change0.18%
1 Year Change40.98%
3 Year Change69.39%
5 Year Change82.49%
Change since IPO-30.43%

Recent News & Updates

Recent updates

Shareholder Returns

2372JP HealthcareJP Market
7D7.6%-2.0%-1.5%
1Y41.0%-9.4%13.7%

Return vs Industry: 2372 exceeded the JP Healthcare industry which returned -9.4% over the past year.

Return vs Market: 2372 exceeded the JP Market which returned 13.7% over the past year.

Price Volatility

Is 2372's price volatile compared to industry and market?
2372 volatility
2372 Average Weekly Movement2.7%
Healthcare Industry Average Movement3.3%
Market Average Movement3.6%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 2372 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 2372's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,029Toyotaka Moriwww.iromgroup.co.jp

I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the research and development of pharmaceuticals and medical technologies; cell banking business; and contract manufacturing of products that applies medical technology to cosmetics, etc. It also supports medical institutions in conducting clinical trials; provides substitution and support for the work of pharmaceutical companies and academia that are involved in clinical research, including clinical trials of pharmaceuticals, medical devices, regenerative medicine, and other products; and operates clinic malls and other facilities. The company was formerly known as I'Rom Holdings Co., Ltd.

I'rom Group Co., Ltd. Fundamentals Summary

How do I'rom Group's earnings and revenue compare to its market cap?
2372 fundamental statistics
Market capJP¥33.69b
Earnings (TTM)JP¥258.00m
Revenue (TTM)JP¥17.89b

130.6x

P/E Ratio

1.9x

P/S Ratio

Is 2372 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2372 income statement (TTM)
RevenueJP¥17.89b
Cost of RevenueJP¥10.80b
Gross ProfitJP¥7.09b
Other ExpensesJP¥6.83b
EarningsJP¥258.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 07, 2025

Earnings per share (EPS)21.31
Gross Margin39.63%
Net Profit Margin1.44%
Debt/Equity Ratio135.7%

How did 2372 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

I'rom Group Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.